Study design
We performed a prospective cohort study on a patient diagnosed with
COVID-19 admitted to Al-Shafaa center for corona pandemic in the medical
city, Baghdad, Iraq from July 18, 2020, to August 28, 2020. All patients
included were adults (age >18 years) and confirmed to be
infected with SARS-CoV-2 by polymerase chain reaction testing of a
nasopharyngeal or oropharyngeal swab sample.
The study approved by the institution’s higher scientific Ethics
Committee of Baghdad teaching hospital. All patient were signed an
official consent form to enrolled in this study and agree to use their
results. All patients follow COVID-19 treatment protocol approved by the
ministry of health in Iraq.